NORTHWEST HEALTHCARE PRO (NWH-DB-I.CA) Stock Fundamental Analysis

Canada • Toronto Stock Exchange • TSX:NWH-DB-I • CA667495AK14

104.45 CAD
+0.44 (+0.42%)
Last: Feb 5, 2026, 07:00 PM
Overview Stock Chart Technical Analysis News
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to NWH-DB-I. NWH-DB-I was compared to 38 industry peers in the Diversified REITs industry. While NWH-DB-I is still in line with the averages on profitability rating, there are concerns on its financial health. NWH-DB-I is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • In the past year NWH-DB-I was profitable.
  • NWH-DB-I had a positive operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: NWH-DB-I reported negative net income in multiple years.
  • Each year in the past 5 years NWH-DB-I had a positive operating cash flow.
NWH-DB-I.CA Yearly Net Income VS EBIT VS OCF VS FCFNWH-DB-I.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M

1.2 Ratios

  • NWH-DB-I's Return On Assets of 0.82% is in line compared to the rest of the industry. NWH-DB-I outperforms 52.63% of its industry peers.
  • NWH-DB-I has a Return On Equity (3.06%) which is in line with its industry peers.
  • NWH-DB-I has a Return On Invested Capital of 3.41%. This is in the lower half of the industry: NWH-DB-I underperforms 68.42% of its industry peers.
  • NWH-DB-I had an Average Return On Invested Capital over the past 3 years of 3.40%. This is below the industry average of 5.49%.
  • The last Return On Invested Capital (3.41%) for NWH-DB-I is above the 3 year average (3.40%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 0.82%
ROE 3.06%
ROIC 3.41%
ROA(3y)-2.92%
ROA(5y)0.56%
ROE(3y)-11.33%
ROE(5y)0.68%
ROIC(3y)3.4%
ROIC(5y)3.4%
NWH-DB-I.CA Yearly ROA, ROE, ROICNWH-DB-I.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10

1.3 Margins

  • With a Profit Margin value of 11.90%, NWH-DB-I perfoms like the industry average, outperforming 52.63% of the companies in the same industry.
  • NWH-DB-I has a better Operating Margin (61.05%) than 76.32% of its industry peers.
  • NWH-DB-I's Operating Margin has declined in the last couple of years.
  • NWH-DB-I has a better Gross Margin (74.32%) than 81.58% of its industry peers.
  • NWH-DB-I's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 61.05%
PM (TTM) 11.9%
GM 74.32%
OM growth 3Y-1.41%
OM growth 5Y-1.82%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.75%
GM growth 5Y-0.16%
NWH-DB-I.CA Yearly Profit, Operating, Gross MarginsNWH-DB-I.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), NWH-DB-I is destroying value.
  • NWH-DB-I has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, NWH-DB-I has more shares outstanding
  • The debt/assets ratio for NWH-DB-I has been reduced compared to a year ago.
NWH-DB-I.CA Yearly Shares OutstandingNWH-DB-I.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
NWH-DB-I.CA Yearly Total Debt VS Total AssetsNWH-DB-I.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

  • An Altman-Z score of 3.49 indicates that NWH-DB-I is not in any danger for bankruptcy at the moment.
  • With an excellent Altman-Z score value of 3.49, NWH-DB-I belongs to the best of the industry, outperforming 94.74% of the companies in the same industry.
  • The Debt to FCF ratio of NWH-DB-I is 24.51, which is on the high side as it means it would take NWH-DB-I, 24.51 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of NWH-DB-I (24.51) is worse than 68.42% of its industry peers.
  • NWH-DB-I has a Debt/Equity ratio of 1.47. This is a high value indicating a heavy dependency on external financing.
  • NWH-DB-I has a worse Debt to Equity ratio (1.47) than 68.42% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.47
Debt/FCF 24.51
Altman-Z 3.49
ROIC/WACC0.45
WACC7.55%
NWH-DB-I.CA Yearly LT Debt VS Equity VS FCFNWH-DB-I.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.3 Liquidity

  • A Current Ratio of 0.16 indicates that NWH-DB-I may have some problems paying its short term obligations.
  • NWH-DB-I has a worse Current ratio (0.16) than 65.79% of its industry peers.
  • NWH-DB-I has a Quick Ratio of 0.16. This is a bad value and indicates that NWH-DB-I is not financially healthy enough and could expect problems in meeting its short term obligations.
  • NWH-DB-I's Quick ratio of 0.16 is on the low side compared to the rest of the industry. NWH-DB-I is outperformed by 65.79% of its industry peers.
Industry RankSector Rank
Current Ratio 0.16
Quick Ratio 0.16
NWH-DB-I.CA Yearly Current Assets VS Current LiabilitesNWH-DB-I.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. Growth

3.1 Past

  • NWH-DB-I shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 109.98%, which is quite impressive.
  • NWH-DB-I shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -32.34%.
  • The Revenue has been growing slightly by 4.78% on average over the past years.
EPS 1Y (TTM)109.98%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%111.53%
Revenue 1Y (TTM)-32.34%
Revenue growth 3Y7.27%
Revenue growth 5Y4.78%
Sales Q2Q%-2.55%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NWH-DB-I.CA Yearly Revenue VS EstimatesNWH-DB-I.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M
NWH-DB-I.CA Yearly EPS VS EstimatesNWH-DB-I.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 0.5 1 1.5

More info and screens

Find the best growth stocksShow best growing peers

1

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 522.25 indicates a quite expensive valuation of NWH-DB-I.
  • The rest of the industry has a similar Price/Earnings ratio as NWH-DB-I.
  • NWH-DB-I is valuated expensively when we compare the Price/Earnings ratio to 28.06, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 522.25
Fwd PE N/A
NWH-DB-I.CA Price Earnings VS Forward Price EarningsNWH-DB-I.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • NWH-DB-I's Enterprise Value to EBITDA is on the same level as the industry average.
  • NWH-DB-I's Price/Free Cash Flow ratio is rather expensive when compared to the industry. NWH-DB-I is more expensive than 92.11% of the companies in the same industry.
Industry RankSector Rank
P/FCF 219.92
EV/EBITDA 112.56
NWH-DB-I.CA Per share dataNWH-DB-I.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 10.04%, NWH-DB-I is a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 7.11, NWH-DB-I pays a better dividend. On top of this NWH-DB-I pays more dividend than 94.74% of the companies listed in the same industry.
  • NWH-DB-I's Dividend Yield is rather good when compared to the S&P500 average which is at 1.80.
Industry RankSector Rank
Dividend Yield 10.04%

5.2 History

  • The dividend of NWH-DB-I decreases each year by -13.72%.
  • NWH-DB-I is new to the dividend game and has less than 3 years of track record.
Dividend Growth(5Y)-13.72%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • 154.63% of the earnings are spent on dividend by NWH-DB-I. This is not a sustainable payout ratio.
DP154.63%
EPS Next 2YN/A
EPS Next 3YN/A
NWH-DB-I.CA Yearly Income VS Free CF VS DividendNWH-DB-I.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M
NWH-DB-I.CA Dividend Payout.NWH-DB-I.CA Dividend Payout, showing the Payout Ratio.NWH-DB-I.CA Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

NORTHWEST HEALTHCARE PRO

TSX:NWH-DB-I (2/5/2026, 7:00:00 PM)

104.45

+0.44 (+0.42%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)11-11
Earnings (Next)02-24
Inst Owners10.73%
Inst Owner ChangeN/A
Ins Owners0.39%
Ins Owner ChangeN/A
Market Cap26.11B
Revenue(TTM)417.64M
Net Income(TTM)49.70M
Analysts70
Price Target109.86 (5.18%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 10.04%
Yearly Dividend0.32
Dividend Growth(5Y)-13.72%
DP154.63%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-10.59%
PT rev (3m)-5.22%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 522.25
Fwd PE N/A
P/S 62.52
P/FCF 219.92
P/OCF 216.67
P/B 16.09
P/tB 16.97
EV/EBITDA 112.56
EPS(TTM)0.2
EY0.19%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.47
FCFY0.45%
OCF(TTM)0.48
OCFY0.46%
SpS1.67
BVpS6.49
TBVpS6.15
PEG (NY)N/A
PEG (5Y)N/A
Graham Number5.41
Profitability
Industry RankSector Rank
ROA 0.82%
ROE 3.06%
ROCE 4.73%
ROIC 3.41%
ROICexc 3.46%
ROICexgc 3.52%
OM 61.05%
PM (TTM) 11.9%
GM 74.32%
FCFM 28.43%
ROA(3y)-2.92%
ROA(5y)0.56%
ROE(3y)-11.33%
ROE(5y)0.68%
ROIC(3y)3.4%
ROIC(5y)3.4%
ROICexc(3y)3.44%
ROICexc(5y)3.45%
ROICexgc(3y)3.5%
ROICexgc(5y)3.52%
ROCE(3y)4.73%
ROCE(5y)4.72%
ROICexgc growth 3Y6.32%
ROICexgc growth 5Y0.97%
ROICexc growth 3Y6.47%
ROICexc growth 5Y1.1%
OM growth 3Y-1.41%
OM growth 5Y-1.82%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.75%
GM growth 5Y-0.16%
F-Score5
Asset Turnover0.07
Health
Industry RankSector Rank
Debt/Equity 1.47
Debt/FCF 24.51
Debt/EBITDA 9.29
Cap/Depr 80.78%
Cap/Sales 0.43%
Interest Coverage 1.76
Cash Conversion 46.86%
Profit Quality 238.9%
Current Ratio 0.16
Quick Ratio 0.16
Altman-Z 3.49
F-Score5
WACC7.55%
ROIC/WACC0.45
Cap/Depr(3y)24.87%
Cap/Depr(5y)24.57%
Cap/Sales(3y)0.11%
Cap/Sales(5y)0.11%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)109.98%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%111.53%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-32.34%
Revenue growth 3Y7.27%
Revenue growth 5Y4.78%
Sales Q2Q%-2.55%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-35%
EBIT growth 3Y5.76%
EBIT growth 5Y2.88%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-13.08%
FCF growth 3Y-11.68%
FCF growth 5Y-7.73%
OCF growth 1Y-11.91%
OCF growth 3Y-11.5%
OCF growth 5Y-7.59%

NORTHWEST HEALTHCARE PRO / NWH-DB-I.CA FAQ

Can you provide the ChartMill fundamental rating for NORTHWEST HEALTHCARE PRO?

ChartMill assigns a fundamental rating of 3 / 10 to NWH-DB-I.CA.


What is the valuation status of NORTHWEST HEALTHCARE PRO (NWH-DB-I.CA) stock?

ChartMill assigns a valuation rating of 1 / 10 to NORTHWEST HEALTHCARE PRO (NWH-DB-I.CA). This can be considered as Overvalued.


Can you provide the profitability details for NORTHWEST HEALTHCARE PRO?

NORTHWEST HEALTHCARE PRO (NWH-DB-I.CA) has a profitability rating of 4 / 10.


What are the PE and PB ratios of NORTHWEST HEALTHCARE PRO (NWH-DB-I.CA) stock?

The Price/Earnings (PE) ratio for NORTHWEST HEALTHCARE PRO (NWH-DB-I.CA) is 522.25 and the Price/Book (PB) ratio is 16.09.


What is the financial health of NORTHWEST HEALTHCARE PRO (NWH-DB-I.CA) stock?

The financial health rating of NORTHWEST HEALTHCARE PRO (NWH-DB-I.CA) is 2 / 10.